Tracking tDCS induced grey matter changes in episodic migraine: a randomized controlled trial

• Published in: Journal of headache and pain 2021-11, Vol.22 (1), p.139-11, Article 139
• Main Authors: Schading, Simon, Pohl, Heiko, Gantenbein, Andreas, Luechinger, Roger, Sandor, Peter, Riederer, Franz, Freund, Patrick, Michels, Lars
• Format: Article
• Language: English
• Subjects: Brain plasticity; Brain research; Clinical trials; Cross-Sectional Studies; Electrical stimulation of the brain; ESB; Gray Matter - diagnostic imaging; Headache; Humans; Internal Medicine; Magnetic resonance imaging; Medicine; Medicine & Public Health; Migraine; Migraine Disorders - diagnostic imaging; Migraine Disorders - therapy; Morphometry; Neuroimaging; Neurology; Pain Medicine; Pain perception; Pathophysiology; Research Article; Single-Blind Method; Structural alterations; Structural MRI; Substantia grisea; Transcranial Direct Current Stimulation; Voxel-based morphometry
• ISSN: 1129-2369; 1129-2377; 1129-2377
• DOI: 10.1186/s10194-021-01347-y

Background Occipital transcranial direct current stimulation (tDCS) is an effective and safe treatment for migraine attack prevention. Structural brain alterations have been found in migraineurs in regions related to pain modulation and perception, including occipital areas. However, whether these structural alterations can be dynamically modulated through tDCS treatment is understudied. Objective To track longitudinally grey matter volume changes in occipital areas in episodic migraineurs during and up to five months after occipital tDCS treatment in a single-blind, and sham-controlled study. Methods 24 episodic migraineurs were randomized to either receive verum or sham occipital tDCS treatment for 28 days. To investigate dynamic grey matter volume changes patients underwent structural MRI at baseline (prior to treatment), 1.5 months and 5.5 months (after completion of treatment). 31 healthy controls were scanned with the same MRI protocol. Morphometry measures assessed rate of changes over time and between groups by means of tensor-based morphometry. Results Before treatment, migraineurs reported 5.6 monthly migraine days on average. A cross-sectional analysis revealed grey matter volume increases in the left lingual gyrus in migraineurs compared to controls. Four weeks of tDCS application led to a reduction of 1.9 migraine days/month and was paralleled by grey matter volume decreases in the left lingual gyrus in the treatment group; its extent overlapping with that seen at baseline. Conclusion This study shows that migraineurs have increased grey matter volume in the lingual gyrus, which can be modified by tDCS. Tracking structural plasticity in migraineurs provides a potential neuroimaging biomarker for treatment monitoring. Trial registration ClinicalTrials.gov , NCT03237754 . Registered 03 August 2017 – retrospectively registered, https://clinicaltrials.gov/ct2/show/NCT03237754 .